
Novel Mirk киназы ингибитор, inhibiting DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites, blocking the in vivo growth of pancreatic cancer cells
Novel Mirk kinase inhibitor, inhibiting DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites, blocking the in vivo growth of pancreatic cancer cells
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.